Have you ever heard of Pfizer (ticker symbol: PFE), a U.S. stock?
It is a pharmaceutical company in the United States.
In this article, I would like to introduce Pfizer’s financial results for the period from January to March 2021, which were announced on May 4, 2021.
January to March 2021
EPS is 93¢ vs. 78¢ expected.
Net sales were $14.58 billion, compared to the forecast of $13.41 billion.
Sales growth rate was 44.6% YoY.
Excluding sales of new coronary vaccine, sales growth rate was +8% YoY.